CD4+ T cell subset differentiation and avidity setpoint are dictated by the interplay of cytokine and antigen mediated signals

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Shiner, Erin K ^a   Holbrook, Beth C ^a   Alexander Miller, Martha A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD4 ANTIGEN; CYTOKINE; HERMES ANTIGEN; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 17; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL FATE; CELL LINEAGE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; GENE EXPRESSION; GENETICS; IMMUNOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; CELL DIFFERENTIATION; GENE EXPRESSION; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-4; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SIGNAL TRANSDUCTION; TH1 CELLS; TH17 CELLS; TH2 CELLS;

EID: 84903287101     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100175     Document Type: Article

References (53)

1. Zhu J, Yamane H, Paul WE (2010) Differentiation of effector CD4 T cell populations. Annu Rev Immunol 28: 445-489.
2. Strutt TM, McKinstry KK, Dibble JP, Winchell C, Kuang Y, et al. (2010) Memory CD4+ T cells induce innate responses independently of pathogen. Nat Med 16: 558-64, 1p.
3. Brown DM, Dilzer AM, Meents DL, Swain SL (2006) CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch. J Immunol 177: 2888-2898. (Pubitemid 44277804)
4. McKinstry KK, Strutt TM, Kuang Y, Brown DM, Sell S, et al. (2012) Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms. J Clin Invest 122: 2847-2856.
5. McGeachy MJ, McSorley SJ (2012) Microbial-induced Th17: superhero or supervillain? J Immunol 189: 3285-3291.
6. Nakayama T, Yamashita M (2010) The TCR-mediated signaling pathways that control the direction of helper T cell differentiation. Semin Immunol 22: 303-309.
7. Yamashita M, Katsumata M, Iwashima M, Kimura M, Shimizu C, et al. (2000) T cell receptor-induced calcineurin activation regulates T helper type 2 cell development by modifying the interleukin 4 receptor signaling complex. J Exp Med 191: 1869-1879. (Pubitemid 30390350)
8. Purvis HA, Stoop JN, Mann J, Woods S, Kozijn AE, et al. (2010) Low-strength T-cell activation promotes Th17 responses. Blood 116: 4829-4837.
9. + T cells. J Exp Med 182: 1591-1596.
10. + T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J Exp Med 182: 1579-1584.
11. + T cell responses: The alternative approaches. Annu Rev Immunol 15: 297-322.
12. Alexander-Miller MA, Leggatt GR, Berzofsky JA (1996) Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc Natl Acad Sci USA 93: 4102-4107. (Pubitemid 26144250)
13. Derby M, Alexander-Miller M, Tse R, Berzofsky J (2001) High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL. J Immunol 166: 1690-1697. (Pubitemid 32114651)
14. Gallimore A, Dumrese T, Hengartner H, Zinkernagel RM, Rammensee HG (1998) Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides. J Exp Med 187: 1647-1657. (Pubitemid 28235106)
15. Sedlik C, Dadaglio G, Saron MF, Deriaud E, Rojas M, et al. (2000) In vivo induction of a high-avidity, high-frequency cytotoxic T- lymphocyte response is associated with antiviral protective immunity. J Virol 74: 5769-5775. (Pubitemid 30412943)
16. Zeh HJ, III, Perry-Lalley D, Dudley ME, Rosenberg SA, Yang JC (1999) High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy. J Immunol 162: 989-994. (Pubitemid 29035425)
17. Yee C, Savage PA, Lee PP, Davis MM, Greenberg PD (1999) Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. J Immunol 162: 2227-2234. (Pubitemid 29288845)
18. Neveu B, Debeaupuis E, Echasserieau K, Moullac-Vaidye B, Gassin M, et al. (2008) Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection. Hepatology 48: 713-722.
19. Almeida JR, Price DA, Papagno L, Arkoub ZA, Sauce D, et al. (2007) Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J Exp Med 204: 2473-2485. (Pubitemid 47529331)
20. Almeida JR, Sauce D, Price DA, Papagno L, Shin SY, et al. (2009) Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. Blood 113: 6351-6360.
21. Cawthon AG, Lu H, Alexander-Miller MA (2001) Peptide requirement for CTL activation reflects the sensitivity to CD3 engagement: Correlation with CD8ab versus CD8aa expression. J Immunol 167: 2577-2584. (Pubitemid 32768885)
22. Kroger CJ, Alexander-Miller MA (2007) Cutting edge: CD8+ T cell clones possess the potential to differentiate into both high- and low-avidity effector cells. J Immunol 179: 748-751.
23. + T cell responses in vivo and in vitro. Proc Natl Acad Sci USA 96: 9781-9786.
24. + T cells specific for GAD65. Autoimmunity 43: 573-582.
25. Barnden MJ, Allison J, Heath WR, Carbone FR (1998) Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol 76: 34-40. (Pubitemid 28194695)
26. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, et al. (1992) Rag-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-877.
27. Cote-Sierra J, Foucras G, Guo L, Chiodetti L, Young HA, et al. (2004) Interleukin 2 plays a central role in Th2 differentiation. Proc Natl Acad Sci U S A 101: 3880-3885. (Pubitemid 38381071)
28. Jorritsma PJ, Brogdon JL, Bottomly K (2003) Role of TCR-induced extracellular signal-regulated kinase activation in the regulation of early IL-4 expression in naive CD4+ T cells. J Immunol 170: 2427-2434. (Pubitemid 36245630)
29. Veldhoen M, Hirota K, Christensen J, O'Garra A, Stockinger B (2009) Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J Exp Med 206: 43-49.
30. Gomez-Rodriguez J, Sahu N, Handon R, Davidson TS, Anderson SM, et al. (2009) Differential expression of interleukin-17A and -17F is coupled to T cell receptor signaling via inducible T cell kinase. Immunity 31: 587-597.
31. Muranski P, Borman ZA, Kerkar SP, Klebanoff CA, Ji Y, et al. (2011) Th17 cells are long lived and retain a stem cell-like molecular signature. Immunity 35: 972-985.
32. Cawthon AG, Alexander-Miller MA (2002) Optimal colocalization of TCR and CD8 as a novel mechanism for the control of functional avidity. J Immunol 169: 3492-3498.
33. Kroger CJ, Alexander-Miller MA (2007) Dose-dependent modulation of CD8 and functional avidity as a result of peptide encounter. Immunology 122: 167-178. (Pubitemid 47389945)
34. Connors M, Giese NA, Kulkarni AB, Firestone CY, Morse HC III, et al. (1994) Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. J Virol 68: 5321-5325. (Pubitemid 24226607)
35. McKinstry KK, Strutt TM, Buck A, Curtis JD, Dibble JP, et al. (2009) IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J Immunol 182: 7353-7363.
36. Waite JC, Skokos D (2012) Th17 response and inflammatory autoimmune diseases. Int J Inflam 2012: 819467.
37. + T cells - Optimal soldiers in the war against viruses and tumors. Immunol Res 31: 13-24.
38. Tamura T, Nakano H, Nagase H, Morokata T, Igarashi O, et al. (1995) Early activation signal transduction pathways of Th1 and Th2 cell clones stimulated with anti-CD3. Roles of protein tyrosine kinases in the signal for IL-2 and IL-4 production. J Immunol 155: 4692-4701.
39. Sloan-Lancaster J, Steinberg TH, Allen PM (1997) Selective loss of the calcium ion signaling pathway in T cells maturing toward a T helper 2 phenotype. J Immunol 159: 1160-1168. (Pubitemid 127484091)
40. Gajewski TF, Schell SR, Fitch FW (1990) Evidence implicating utilization of different T cell receptor-associated signaling pathways by TH1 and TH2 clones. J Immunol 144: 4110-4120. (Pubitemid 20187745)
41. Balamuth F, Leitenberg D, Unternaehrer J, Mellman I, Bottomly K (2001) Distinct patterns of membrane microdomain partitioning in Th1 and Th2 cells. Immunity 15: 729-738. (Pubitemid 34008501)
42. Thauland TJ, Koguchi Y, Wetzel SA, Dustin ML, Parker DC (2008) Th1 and Th2 cells form morphologically distinct immunological synapses. J Immunol 181: 393-399.
43. Yoo JK, Cho JH, Lee SW, Sung YC (2002) IL-12 provides proliferation and survival signals to murine CD4+ T cells through phosphatidylinositol 3-kinase/Akt signaling pathway. J Immunol 169: 3637-3643.
44. Wurster AL, Withers DJ, Uchida T, White MF, Grusby MJ (2002) Stat6 and IRS-2 cooperate in interleukin 4 (IL-4)-induced proliferation and differentiation but are dispensable for IL-4-dependent rescue from apoptosis. Mol Cell Biol 22: 117-126. (Pubitemid 33144261)
45. Vella A, Teague TK, Ihle J, Kappler J, Marrack P (1997) Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4. J Exp Med 186: 325-330. (Pubitemid 27328033)
46. Dienz O, Rincon M (2009) The effects of IL-6 on CD4 T cell responses. Clin Immunol 130: 27-33.
47. Choi S, Schwartz RH (2007) Molecular mechanisms for adaptive tolerance and other T cell anergy models. Semin Immunol 19: 140-152. (Pubitemid 46824071)
48. Quill H, Riley MP, Cho EA, Casnellie JE, Reed JC, et al. (1992) Anergic Th1 cells express altered levels of the protein tyrosine kinases p56lck and p59fyn. J Immunol 149: 2887-2893.
49. Chiodetti L, Choi S, Barber DL, Schwartz RH (2006) Adaptive tolerance and clonal anergy are distinct biochemical states. J Immunol 176: 2279-2291. (Pubitemid 43201675)
50. Jeon MS, Atfield A, Venuprasad K, Krawczyk C, Sarao R, et al. (2004) Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. Immunity 21: 167-177. (Pubitemid 39094047)
51. Safford M, Collins S, Lutz MA, Allen A, Huang CT, et al. (2005) Egr-2 and Egr-3 are negative regulators of T cell activation. Nat Immunol 6: 472-480. (Pubitemid 41716760)
52. Seroogy CM, Soares L, Ranheim EA, Su L, Holness C, et al. (2004) The gene related to anergy in lymphocytes, an E3 ubiquitin ligase, is necessary for anergy induction in CD4 T cells. J Immunol 173: 79-85. (Pubitemid 38797328)
53. + CTL avidity. Eur J Immunol 39: 1819-1830.